Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)

Overview of attention for article published in Breast Cancer Research and Treatment, April 2019

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

岸和田市乳腺外科専門医のページ, 17 Apr 2019

Trastuzumab・pertuzumab・T-DM1 投与後のHER2 陽性転移性乳がんにおいて、lapatinib ベース治療は一定の抗腫瘍効果を示す (文献2019-087)。 "Lapatinib activity in metastatic…